《Medicalxpress,11月22日,Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape》

  • 来源专题:COVID-19科研动态监测
  • 编译者: YUTING
  • 发布时间:2021-11-27
  • SARS-CoV-2 variants of concern exhibit varying degrees of transmissibility and, in some cases, escape from acquired immunity. Much effort has been devoted to measuring these phenotypes, but understanding their impact on the course of the pandemic – especially that of immune escape – has remained a challenge. Here, we use a mathematical model to simulate the dynamics of wildtype and variant strains of SARS-CoV-2 in the context of vaccine rollout and nonpharmaceutical interventions. We show that variants with enhanced transmissibility frequently increase epidemic severity, whereas those with partial immune escape either fail to spread widely, or primarily cause reinfections and breakthrough infections. However, when these phenotypes are combined, a variant can continue spreading even as immunity builds up in the population, limiting the impact of vaccination and exacerbating the epidemic. These findings help explain the trajectories of past and present SARS-CoV-2 variants and may inform variant assessment and response in the future.

  • 原文来源:https://medicalxpress.com/news/2021-11-blood-t-cell-antibody-response-sars-cov-.html
相关报告
  • 《Cell,3月12日,Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-03-22
    • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Wilfredo F. Garcia-Beltran 12 Evan C. Lam 12 Kerri St. Denis 12 A. John Iafrate Vivek Naranbhai Alejandro B. Balazs 13 Show all authors Show footnotes Open AccessPublished:March 12, 2021DOI:https://doi.org/10.1016/j.cell.2021.03.013 Summary Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However, ongoing surveillance has revealed the emergence of variants harboring mutations in spike, the main target of neutralizing antibodies. To understand the impact of these variants, we evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2. Five of the 10 pseudoviruses, harboring receptor-binding domain mutations, including K417N/T, E484K, and N501Y, were highly resistant to neutralization. Cross-neutralization of B.1.351 variants was comparable to SARS-CoV and bat-derived WIV1-CoV, suggesting that a relatively small number of mutations can mediate potent escape from vaccine responses. While the clinical impact of neutralization resistance remains uncertain, these results highlight the potential for variants to escape from neutralizing humoral immunity and emphasize the need to develop broadly protective interventions against the evolving pandemic.
  • 《Science,3月3日,Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-03-09
    • Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Nicholas G. Davies1,*, View ORCID ProfileSam Abbott1,†, View ORCID ProfileRosanna C. Barnard1,†, View ORCID ProfileChristopher I. Jarvis1,†, Adam J. Kucharski1,†,... Science  03 Mar 2021: eabg3055 DOI: 10.1126/science.abg3055 Abstract A novel SARS-CoV-2 variant, VOC 202012/01 (lineage B.1.1.7), emerged in southeast England in November 2020 and is rapidly spreading toward fixation. Using a variety of statistical and dynamic modelling approaches, we estimate that this variant has a 43–90% (range of 95% credible intervals 38–130%) higher reproduction number than preexisting variants. A fitted two-strain dynamic transmission model shows that VOC 202012/01 will lead to large resurgences of COVID-19 cases. Without stringent control measures, including limited closure of educational institutions and a greatly accelerated vaccine roll-out, COVID-19 hospitalisations and deaths across England in 2021 will exceed those in 2020. Concerningly, VOC 202012/01 has spread globally and exhibits a similar transmission increase (59–74%) in Denmark, Switzerland, and the United States.